4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001209191-16-135934
CIK 0001328143operating
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 5:45 PM ET
Size
5.5 KB
Accession
0001209191-16-135934
Insider Transaction Report
Form 4
MacPhee John A
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-08-05+12,600→ 12,600 totalExercise: $13.68Exp: 2026-08-04→ Common Stock (12,600 underlying)
Footnotes (1)
- [F1]The Option shares shall vest as follows: 100% of the option shares shall vest on the date 1 year from August 5, 2016, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 5:45 PM ET
- Size
- 5.5 KB